scispace - formally typeset
Search or ask a question
Institution

Solvay

CompanyBrussels, Belgium
About: Solvay is a company organization based out in Brussels, Belgium. It is known for research contribution in the topics: Catalysis & Polymerization. The organization has 6083 authors who have published 7004 publications receiving 105745 citations.


Papers
More filters
Journal ArticleDOI
20 Apr 2012-Science
TL;DR: It is shown that surface modifiers based on polymers containing simple aliphatic amine groups substantially reduce the work function of conductors including metals, transparent conductive metal oxides, conducting polymers, and graphene.
Abstract: Organic and printed electronics technologies require conductors with a work function that is sufficiently low to facilitate the transport of electrons in and out of various optoelectronic devices. We show that surface modifiers based on polymers containing simple aliphatic amine groups substantially reduce the work function of conductors including metals, transparent conductive metal oxides, conducting polymers, and graphene. The reduction arises from physisorption of the neutral polymer, which turns the modified conductors into efficient electron-selective electrodes in organic optoelectronic devices. These polymer surface modifiers are processed in air from solution, providing an appealing alternative to chemically reactive low–work function metals. Their use can pave the way to simplified manufacturing of low-cost and large-area organic electronic technologies.

1,870 citations

Journal ArticleDOI
TL;DR: The authors conclude that CYP2E1 shows no large differences between species, and extrapolation between species appears to hold quite well, and the species-specific isoforms of CYP1A, -2C, -1D and -3A show appreciable interspecies differences in terms of catalytic activity and some caution should be applied when extrapolating metabolism data from animal models to humans.
Abstract: Animal models are commonly used in the preclinical development of new drugs to predict the metabolic behaviour of new compounds in humans. It is, however, important to realise that humans differ from animals with regards to isoform composition, expression and catalytic activities of drug-metabolising enzymes. In this review the authors describe similarities and differences in this respect among the different species, including man. This may be helpful for drug researchers to choose the most relevant animal species in which the metabolism of a compound can be studied for extrapolating the results to humans. The authors focus on CYPs, which are the main enzymes involved in numerous oxidative reactions and often play a critical role in the metabolism and pharmacokinetics of xenobiotics. In addition, induction and inhibition of CYPs are compared among species. The authors conclude that CYP2E1 shows no large differences between species, and extrapolation between species appears to hold quite well. In contrast, the species-specific isoforms of CYP1A, -2C, -2D and -3A show appreciable interspecies differences in terms of catalytic activity and some caution should be applied when extrapolating metabolism data from animal models to humans.

1,155 citations

Journal ArticleDOI
R. Spotnitz, J. Franklin1
TL;DR: In this article, a set of exothermic reactions with corresponding estimates of heats of reaction is selected with corresponding designs for high-rate batteries, along with estimated kinetic parameters and models for the abuse behavior (oven, short-circuit, overcharge, nail, crush).

927 citations

Journal ArticleDOI
TL;DR: The lymphoid and respiratory systems have the most remarkable lesions and appear to be the major site of replication of these viruses.
Abstract: One hundred 4-week-old cesarean-derived colostrum-deprived pigs were inoculated with one of two different US porcine reproductive and respiratory syndrome virus (PRRSV) isolates (VR2385, VR2431) or the European Lelystad virus to detect and compare the location and amount of virus antigen. Interstitial pneumonia, myocarditis, lymphadenopathy, and encephalitis were consistently seen in all three groups; however, disease and lesions were more severe in the VR2385 group. Immunohistochemical evaluation of formalin-fixed tissues revealed virus antigen in alveolar macrophages in lungs of 22/25, 14/25, 14/25, and 0/25 of the VR2385, VR2431, Lelystad, and control pigs, respectively. Follicular macrophages and dendritic cells in the lymph nodes of 14/25, 10/25, 10/25, and 0/25 pigs from the VR2385, VR2431, Lelystad, and control groups, respectively, stained positive for virus antigen. Similar cells in the tonsils from 25/25, 21/25, 23/25, and 0/25 pigs from the VR2385, VR2431, Lelystad, and control groups, respectively, stained positive for virus antigen. Other tissues and cells in which virus antigen was detected included macrophages and endothelial cells in the heart, macrophages, and interdigitating cells in the thymus, macrophages and dendritic cells in the spleen and Peyer's patches, and macrophages in hepatic sinusoids, renal medullary interstitium, and adrenal gland. PRRSV persisted in macrophages in the lung, tonsil, lymph node, and spleen for at least 28 days. Significantly more PRRSV antigen was detected in the lung (P < 0.01), lymph nodes (P < or = 0.05), and tonsils (P < 0.05) of the VR2385 pigs than was detected in the same tissues of the VR2431 and Lelystad pigs. The cell types in which PRRSV antigen was detected and the distribution of PRRSV antigen-positive cells within particular tissues and organs were generally similar for the different virus inoculation groups despite differences in virulence of the isolates.

698 citations

Journal ArticleDOI
TL;DR: It is proposed that glutamate may be involved in the acute neurodestructive phase that occurs immediately after traumatic or ischaemic injury (excitotoxicity), but that, after this period, it assumes its normal physiological functions, which include promotion of neuronal survival.
Abstract: Glutamate N-methyl-D-aspartate (NMDA) receptor antagonists (competitive receptor antagonists, ion channel blockers, and glycine antagonists)—such as selfotel, aptiganel, eliprodil, licostinel and gavestinel—failed to show efficacy in clinical trials of stroke or traumatic brain injury. This failure has been attributed to the deficient properties of the molecules that entered human trials and to inappropriate design of clinical studies. In this article we hypothesise that glutamate may be involved in the acute neurodestructive phase that occurs immediately after traumatic or ischaemic injury (excitotoxicity), but that, after this period, it assumes its normal physiological functions, which include promotion of neuronal survival. We propose that NMDA receptor antagonists failed stroke and traumatic brain injury trials in human beings because blockade of synaptic transmission mediated by NMDA receptors hinders neuronal survival.

672 citations


Authors

Showing all 6091 results

NameH-indexPapersCitations
Adi F. Gazdar157776104116
Mohammad Khaja Nazeeruddin12964685630
Jack P. Antel10551943950
Philippe Dubois101109848086
Enrico Drioli9598737962
Martin Winter9375145506
Gian F. Giudice9326450392
Johannes Hebebrand9158138408
Michael Graetzel8936043269
Andrew J. Martin8481936203
Alan D. Rogol8146124865
Anthony L. Spek81109059190
William J. Tremaine8028224233
Marc Henneaux7641127840
Stephen Lam7641320693
Network Information
Related Institutions (5)
Centre national de la recherche scientifique
382.4K papers, 13.6M citations

87% related

University of Groningen
69.1K papers, 2.9M citations

87% related

University of Barcelona
108.5K papers, 3.7M citations

86% related

École Normale Supérieure
99.4K papers, 3M citations

85% related

Imperial College London
209.1K papers, 9.3M citations

85% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20232
202226
2021113
2020159
2019139
2018139